Florence, S.C., March 09, 2018 -- DeGen Medical announced the FDA clearance of E3 MIS™ Modular Pedicle Screw System for thoraco-lumbar spine. E3 MIS™ system addresses a wide range of surgical options, pre-assembled or modular screws, straight or curved rods, and titanium or cobalt-chrome rods. It allows the surgeon intra-operative flexibility for bone grafting and screw placement. The screw thread is specifically engineered to combine the option for standard or cortical screw placement.
|
|||
E3 MIS™ System allows surgeons three different MIS towers to choose from inter-operatively in a two-tray configuration.
The E3 MIS™ System features:
- Modular tulip heads and screws compatible with the current F1 MPS™ system and 5.5mm rod offerings.
- Several titanium alloy and cobalt-chrome modular screw head options, including MIS and Spondy.
- A complement of surgical instruments to facilitate MIS and Open approaches.
- Screw sizes starting at 4.0mm diameter (solid) and 4.5mm diameter (cannulated) through 10mm diameter.
- Cortical-cancellous thread design or F1 MPS™ thread design.
- Four different options for percutaneous rod insertion.
- MIS towers range from 11mm to 16mm in diameter.
DeGen Medical would like to thank the following doctors for their contributions to this innovative and versatile system: Dr. Rakesh Chokshi, Dr. P. Douglas deHoll, Dr. Gene Massey, and Dr. Daniel Williams.
About DeGen Medical, Inc.
DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.
For more information, please contact:
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2ed524a9-c64f-4c18-9ba2-985de87ecff0
Jessica McCracken DeGen Medical, Inc. 843-407-0538 [email protected]


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



